Annual EBITDA
-$11.22 M
-$757.10 K-7.24%
March 31, 2023
Summary
- As of February 10, 2025, YS annual EBITDA is -$11.22 million, with the most recent change of -$757.10 thousand (-7.24%) on March 31, 2023.
- During the last 3 years, YS annual EBITDA has risen by +$6.02 million (+34.92%).
Performance
YS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$13.59 M
-$4.73 M-53.33%
September 30, 2023
Summary
- As of February 10, 2025, YS quarterly EBITDA is -$13.59 million, with the most recent change of -$4.73 million (-53.33%) on September 30, 2023.
- Over the past year, YS quarterly EBITDA has dropped by -$15.96 million (-672.32%).
Performance
YS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$22.45 M
-$15.96 M-246.05%
September 30, 2023
Summary
- As of February 10, 2025, YS TTM EBITDA is -$22.45 million, with the most recent change of -$15.96 million (-246.05%) on September 30, 2023.
- Over the past year, YS TTM EBITDA has dropped by -$23.07 million (-3731.03%).
Performance
YS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
YS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.2% | -672.3% | -3731.0% |
| 3 y3 years | +34.9% | -673.9% | -1178.5% |
| 5 y5 years | +34.9% | -673.9% | -1178.5% |
YS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +7.2% | +53.7% | -672.3% | at low | -3731.0% | at low |
| 5 y | 5-year | +7.2% | +53.7% | -672.3% | at low | -3731.0% | at low |
| alltime | all time | +7.2% | +53.7% | -672.3% | at low | -3731.0% | at low |
YS Biopharma Co EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$13.59 M(+53.3%) | -$22.45 M(+246.0%) |
| Jun 2023 | - | -$8.86 M(-473.3%) | -$6.49 M(-1149.3%) |
| Mar 2023 | -$11.22 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $2.37 M(-235.2%) | $618.20 K(-135.2%) |
| Jun 2022 | - | -$1.76 M | -$1.76 M |
| Mar 2022 | -$10.46 M(-39.3%) | - | - |
| Mar 2021 | -$17.24 M | - | - |
FAQ
- What is YS Biopharma Co annual EBITDA?
- What is the all time high annual EBITDA for YS Biopharma Co?
- What is YS Biopharma Co annual EBITDA year-on-year change?
- What is YS Biopharma Co quarterly EBITDA?
- What is the all time high quarterly EBITDA for YS Biopharma Co?
- What is YS Biopharma Co quarterly EBITDA year-on-year change?
- What is YS Biopharma Co TTM EBITDA?
- What is the all time high TTM EBITDA for YS Biopharma Co?
- What is YS Biopharma Co TTM EBITDA year-on-year change?
What is YS Biopharma Co annual EBITDA?
The current annual EBITDA of YS is -$11.22 M
What is the all time high annual EBITDA for YS Biopharma Co?
YS Biopharma Co all-time high annual EBITDA is -$10.46 M
What is YS Biopharma Co annual EBITDA year-on-year change?
Over the past year, YS annual EBITDA has changed by -$757.10 K (-7.24%)
What is YS Biopharma Co quarterly EBITDA?
The current quarterly EBITDA of YS is -$13.59 M
What is the all time high quarterly EBITDA for YS Biopharma Co?
YS Biopharma Co all-time high quarterly EBITDA is $2.37 M
What is YS Biopharma Co quarterly EBITDA year-on-year change?
Over the past year, YS quarterly EBITDA has changed by -$15.96 M (-672.32%)
What is YS Biopharma Co TTM EBITDA?
The current TTM EBITDA of YS is -$22.45 M
What is the all time high TTM EBITDA for YS Biopharma Co?
YS Biopharma Co all-time high TTM EBITDA is $618.20 K
What is YS Biopharma Co TTM EBITDA year-on-year change?
Over the past year, YS TTM EBITDA has changed by -$23.07 M (-3731.03%)